Những podcast Pharmaphorum hay nhất (2024)

1
Challenges and opportunities in synthetic clinical trials 44:01

6d ago44:01

44:01

On today’s episode Web Sun, president and cofounder of Komodo Health and Tracy Mayne, SVP regulatory and life sciences research at Slipstream IT, talk about this trend, where the industry is now, and what they’re doing to move it along.Bởi pharmaphorum

1
The commercialisation of quantum science in pharma 26:03

7d ago26:03

26:03

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.Bởi pharmaphorum

1
Conference report: Reuters Pharma Europe 37:25

12d ago37:25

37:25

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.Bởi pharmaphorum

1
In vitro gametogenesis: the science has to be right, and it has to be safe 16:46

14d ago16:46

16:46

Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).Bởi pharmaphorum

1
Proving ROI for digital endpoints 32:58

19d ago32:58

32:58

Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagement with healthcare providers.Bởi pharmaphorum

1
Clinical trials: their design, location, and, potentially, their simulation 17:09

21d ago17:09

17:09

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.Bởi pharmaphorum

1
Pace, acceleration, and precision are the name of the game 20:34

27d ago20:34

20:34

Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate at speed, and it is such aspects that are central to today’s podcast with Zach Powers, chief information security officer at Benchling, the R&D cloud platform for the biotech industry.…

1
Technology working as the puzzle piece to bring better outcomes to patients 18:28

29d ago18:28

18:28

While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about commercial strategy and digitalising commercial operations.Bởi pharmaphorum

1
Is precision psychiatry possible? 35:38

1M ago35:38

35:38

On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bring precision medicine to psychiatry. But what do we mean when we talk about precision, especially in a discipline like mental health that has historically involved a lot of objectivity?…

1
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape 19:31

1M ago19:31

19:31

In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’s pharmaceutical landscape and leveraging legislation for health and competitiveness.Bởi pharmaphorum

1
Predictions for AI in mental health in the coming year 22:35

1M ago22:35

22:35

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.…

1
Fixing clinical trial data management 26:34

2M ago26:34

26:34

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.…

1
Harnessing the velocity of biopharmaceutical advances 18:10

2M ago18:10

18:10

On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.Bởi pharmaphorum

1
Conference report: Reuters Pharma USA 38:02

2M ago38:02

38:02

Last week, pharmaphorum Editor in Chief Jonah Comstock traveled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive Editor Eloise McLellan about his biggest takeaways from the two-day event.Bởi pharmaphorum

1
The future of AI: Machine learning working together with scientific expertise 10:28

2M ago10:28

10:28

In a new episode of the pharmaphorum podcast recorded live on site at WIRED Health in London in March, web editor Nicole Raleigh spoke with Elise de Reus, co-founder of Cradle, the generative AI platform that helps scientists to design and program proteins.Bởi pharmaphorum

1
Understanding the politics of drug pricing in the United States 35:53

2M ago35:53

35:53

Everyone says they want more affordable drugs for patients that need them, but people disagree quite a bit on who's to blame for the current status quo of sky-high prescription prices – not to mention how they might be corrected. To help unpack some of those trends and conflicting perspectives, Brandon Newman, CEO of healthcare analytics firm Xevan…

1
Female leadership and lessening disease burden 14:59

2M ago14:59

14:59

As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessen…

1
The unique clinical trial challenges faced by digital therapeutics 27:56

2M ago27:56

27:56

On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, cofounder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about often unseen difficulties of validating a digital therapeutic through a clinical trial.Bởi pharmaphorum

1
The unmentionables: Challenging inequalities in women’s health 47:42

2M ago47:42

47:42

As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too. The guests included: Trine Bartholdy, chief innovation executive at the BioInnovation Institute (BII) in Denmark; Kar…

1
The next chapter for AI protein structure prediction 28:01

3M ago28:01

28:01

On today’s pharmaphorum podcast, Glen Gowers, cofounder of Basecamp Research, gets into the company’s recent pre-print paper and how it improves upon AlphaFold 2, the current gold standard for protein folding prediction.Bởi pharmaphorum

1
Avoiding the data swamp: The transformative power of AI 17:56

3M ago17:56

17:56

In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern data platform and Cloud infrastructure for science, to discuss the evolving role of the Cloud in biopharma and some rather revolutionary tools in AI drug discovery.…

1
How natural language processing can make a difference in pharma 22:32

3M ago22:32

22:32

On today’s podcast, host Jonah Comstock welcomes Jane Reed, director of life sciences at IQVIA NLP, the new name for recent IQVIA acquisition Linguamatics. Jane talks through some of these different technologies and use cases and describes how natural language processing has exciting potential in translating real-world conversations on social media…

1
Transitioning from traditional surgical methods to the innovative use of stem cells. 18:35

3M ago18:35

18:35

In today’s podcast, host Nicole Raleigh welcomes Dr Jeffrey Gross, founder of ReCELLebrate, neurological surgeon, and expert in the field of regenerative medicine, to discuss this development. Their conversation delves into the recent appetite for the use of stem cells for longevity and explores the ‘health span’ notion that is being ever more freq…

1
The 2024 biopharma M&A landscape: An overview 31:28

3M ago31:28

31:28

It's been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats. On today’s podcast, host Jonah Comstock is joined by Cody Powers, principal of portfolio and business development at ZS Associates, to discuss those trends and predictions an…

1
Accelerating the process, transforming therapies and advancing precision medicine 22:00

3M ago22:00

22:00

In this episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Mohit Jain, founder and CEO of Sapient, a biomarker discovery lab providing expert services and actionable insights to better personalise disease prediction, diagnostics, and therapies.Bởi pharmaphorum

1
Applying genetics to chemistry to find new small molecules 28:04

3M ago28:04

28:04

For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science. But new technologies are changing that, allowing companies to approach the process with more precise eye. On today’s episode of the pharmaphorum podcast, Jason Park, CEO of Empress Therapeutics, discusses his company's novel a…

1
Opening the digital front door to advanced healthcare 54:38

3M ago54:38

54:38

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about their latest partnership, with its goal of personalised registries and the notion of the digital front door for patient information.…

1
Pharmaceutical research in space 25:46

3M ago25:46

25:46

On today’s podcast, host Jonah Comstock welcomes Christina Corridon, global lead of oncology at ZS Associates and Sandeep Sangwan, who leads the knowledge services R&D team at ZS. They discuss how research conducted in space can advance life sciences research, especially in oncology.Bởi pharmaphorum

1
Precision medicine in mental health - one size really doesn’t fit all 23:55

4M ago23:55

23:55

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomed Dr Hans Eriksson, chief medical officer at HMNC Brain Health, a precision psychiatry biopharma company, to discuss his work exploring current studies into the use of ketamine in mental health, HMNC Brain Health having last year announced topline results from a Phase 2 s…

1
Where are the pharma voices in US politics? 31:45

4M ago31:45

31:45

In today’s episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Jirair Ratevosian, a candidate for California’s 30th District with a doctorate in public health and experience leading infectious disease-fighting efforts for the Biden administration.Bởi pharmaphorum

1
A clearer harmony and attractiveness for EU Clinical Trials Regulation 28:07

4M ago28:07

28:07

For the latest episode of the pharmaphorum podcast, web editor Nicole Raleigh sat down with Chris Bamford, director of clinical trial regulatory management at IQVIA, and Shirley Rutter, associate director and strategic quality lead of global quality management at IQVIA BiotechBởi pharmaphorum

1
Making connections and getting noticed as a biotech start-up 49:21

4M ago49:21

49:21

On today's podcast, brought to you by Kadans Science Partners, host Jonah Comstock is joined by Bradley Hardiman, Astellas Pharma’s Senior Director of Business Development; Mike Murray, head of Murray International Partners Ltd; and Mairi Dillon, Kadans' Ecosystem Manager for UK & Ireland.Bởi pharmaphorum

1
Getting down to the nitty gritty of actively creating healthier societies 23:35

4M ago23:35

23:35

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Stuart Cooper, CEO of Adelphi Group, about Anthropy – a yearly event that aims to spark innovation and foster fresh thinking among diverse leaders – and about creating healthier societies, about biopharma’s role in that, including implementation of preventative methods in…

1
How manufacturing keeps pace with innovation in cell and gene therapy 28:59

4M ago28:59

28:59

On today’s podcast, host Jonah Comstock is joined by Arturo Araya, is EVP of Commercialisation at Cellares, a company that is attempting to create a new kind of contract manufacturing organisation for the rapidly crystalizing world of cell and gene therapy.Bởi pharmaphorum

1
Fixing the inequity of drug access outside of the US 14:43

4M ago14:43

14:43

In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorluhar, CEO of Er-Kim Pharmaceuticals, for a conversation on antimicrobial resistance (AMR) and what the biotech industry should be focussing on in order to address this critical issue outside of the West.…

1
Key themes from JP Morgan 36:24

4M ago36:24

36:24

Editor in Chief Jonah Comstock is back from San Francisco where he attended the annual JP Morgan Healthcare Conference. On today’s episode, guest host Eloise McLennan interviews Jonah about what he saw and heard at the show.Bởi pharmaphorum

1
Prediction is very difficult, especially if it’s about the future 27:43

4M ago27:43

27:43

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acceleration of antibody therapeutics.Bởi pharmaphorum

1
Promoting value-added medicines and renovating old medicines smartly 25:48

5M ago25:48

25:48

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.Bởi pharmaphorum

1
Digitisation of drug R&D: Avoiding new for novelty’s sake 11:07

5M ago11:07

11:07

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.…

1
The problems of animal research for human medicine and the alternatives 21:20

5M ago21:20

21:20

In today’s podcast, web editor Nicole Raleigh speaks with Dr Pandora Pound, a Fellow at the OCAE and research director at the Safer Medicines Trust, a charity aiming to improve the safety of medicines by facilitating a transition to human biology-based drug development and testing.Bởi pharmaphorum

1
The race to develop innovative products and supply chain solutions 24:13

5M ago24:13

24:13

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and SVP and international managing director of Alloga Europe and ICS, Chris Williams. The topic of discussion centres around considerations and challenges when it co…

1
The smart-design evolution of the laboratory space 19:28

5M ago19:28

19:28

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development director at Unispace Life Sciences, exploring how laboratory space requirements have changed since the pandemic.Bởi pharmaphorum

1
Investing in the gleams of positivity and hope for life sciences innovation 28:56

5M ago28:56

28:56

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.Bởi pharmaphorum

1
Looking to the future of UK medical device exports 24:37

5M ago24:37

24:37

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing repres…

1
Exploring the reasons behind increasing burdens on clinical research sites 19:02

5M ago19:02

19:02

In the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, Elisa Cascade, about the reasons behind increasing burdens on clinical research sites over the last five years.Bởi pharmaphorum

1
An investor’s perspective on bio and tech 34:51

5M ago34:51

34:51

In today’s episode of the pharmaphorum podcast, host Jonah Comstock sits down for a wide-ranging conversation with Artem Trotsyuk, an investor with LongeVC. His fund focused on therapeutics, diagnostics, and life sciences infrastructure plays.Bởi pharmaphorum

1
Why digital therapeutics (DTx) are effective and safe, but not being prescribed 20:13

5M ago20:13

20:13

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.…

1
AI drug discovery: Where we are and where we’re going 34:26

6M ago34:26

34:26

Today’s guest is founder and CEO of Exscientia, Andrew Hopkins, who has been named a top AI innovator by TIME and was recently appointed a lifetime fellow to both the Royal Society and the Academy of Medical Sciences in the UK.Bởi pharmaphorum

1
Retaining the human element in healthcare services whilst embracing the potential of robotics 33:53

6M ago33:53

33:53

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Gavin Anderson, a man of many hats all orbiting around technology and business. Trained as a human-centric designer, Anderson helps align business strategy, purpose, and culture and tries to save the planet on the side. But, with his Academy of Robotics hat firmly i…

1
Bringing women’s health up to speed for 21st Century human healthcare 26:56

6M ago26:56

26:56

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the current women’s health landscape and what Mithra is doing on an international scale to ameliorate that.Bởi pharmaphorum

Podcast đáng để nghe

Podcast Pharmaphorum

Podcast đáng để nghe

Hướng dẫn sử dụng nhanh